The Speciality Generic Injectables (SGI) division, a subsidiary of Biological E. Limited, which started in 2013, is the outcome of the company’s efforts to expand the geographical footprint of its Branded Formulations division, which is India-centric. The choice of operating in the injectables space through SGI is predicated on the company’s significant experience in sterile manufacturing. The focus of this new division will be on the development and commercialization of injectable products, primarily Non-Biological Complex Drugs, but also certain routine injectables in order to build a portfolio of both complex and routine injectable products.
The target markets for this division will be primarily the regulated markets, although other markets will be explored as its product offerings continue to evolve.
The US operations of this division commenced in 2019. BE Pharmaceuticals Inc. operates out of Cary, North Carolina, USA.